27 June 2024
27 June 2024
The trial was estimated to enrol approximately 600 patients from 150 sites in the US, Europe, and Asia, with the first patient dosed at the end of 2021.
Research indicates that designing clinical trials with the patient in mind reduces recruitment times and enhances trial performance. Daniel J. Herron, a life sciences specialist, explains why one of the key factors in improving participant involvement is document readability.
The EU regulatory agency states that the shortages are due to higher demand and off-label use of GLP-1 receptor agonists.
A decision on recommending the vaccine for adults aged 50 to 59 years will be made on the availability of additional data.
The collaboration is intended to leverage OpenAI's generative AI-based platform to invent novel antimicrobials to treat drug-resistant pathogens.
The BLA submission for patritumab deruxtecan is facing FDA scrutiny due to third-party manufacturing issues.
The FDA's decision is based on the data from the Phase I/II EPCORE NHL-1 clinical trial.
Biotechs with AI-led drug pipelines appear to be enjoying higher investment attraction.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
